The Trump administration on Friday announced deals with nine drugmakers aimed at lowering pharmaceutical prices, bringing its total number of drug-pricing agreements to 14.
Stocks
-
-
In an inflationary setting, why hold bonds at all, says Louis-Vincent Gave
-
FactSet and Gartner are among the S&P 500’s worst performers this year — but some on Wall Street see resilient and sticky businesses that can adapt to AI.
-
Published on Dec 8, 2025 Share (Investorideas.com Newswire) S&P 500 took a dive 75min before the opening bell, retail enthusiastically bought into…
-
The gold price rose to repeated record highs in 2025, gaining more than 57 percent in value from the start of the year. The increase was fueled by several factors,…
-
Stocks
Strategist who nailed stocks, bonds and oil this year warns of ‘optimism shakeout’ in early 2026
Look for more AI adoption to help broaden the stock market next year, but overly optimistic sentiment may need a reset early on, says strategist Warren Pies.
-
Stocks
Here’s what might turn the tide for value stocks and the broader market over growth stocks in 2026
RBC Capital’s head of U.S. equity strategy, Lori Calvasina, expects the tug-of-war with value stocks and the broader market on one side and Big Tech on the other to continue…
-
Profitability across the Bitcoin mining industry is facing new strain amid rising network competition and declining revenue conditions. Bitcoin miners are facing a fresh squeeze as the network’s hashrate —…
-
Alphabet’s “AI comeback” could be concerning for other AI players in part because the company is leveraging its own custom chips
-
BING-JHEN HONG Investment firm Raymond James believes there is still significantly more upside for a number of semiconductor stocks, including Nvidia (NVDA), AMD (AMD), Intel (INTC) and more. The firm,…
